#United States #Atlanta #AI Readiness #LiminalX #Rayos Contra Cancer

LiminalX and Rayos Contra Cancer Collaboration: Elevating AI Readiness in Radiation Oncology

In a move to enhance the integration of artificial intelligence (AI) within the medical field, LiminalX, a leader in healthcare AI preparedness based in Atlanta, has partnered with Rayos Contra Cancer (RCC), an organization dedicated to providing education and resources in radiation oncology worldwide. This collaboration marks a significant step towards equipping healthcare teams with the necessary tools to navigate the challenges posed by emerging AI technologies in their practice.

The partnership, officially announced during the ASTRO 2026 Annual Meeting in Boston, focuses on incorporating LiminalX's THRIVE platform into RCC's educational programs. This initiative aims to foster a deeper understanding of AI applications within healthcare settings, ensuring that clinical staff across various regions, particularly in underserved communities, can effectively utilize these technologies in their daily operations.

The THRIVE platform offers a structured assessment framework that evaluates the readiness of healthcare professionals in six critical dimensions: Technical, Human, Regulatory, Infrastructure, Value, and Evaluation. Participants using the platform will receive a Human Readiness Level (HRL) score, which highlights their strengths and areas for improvement in AI readiness. This vital information will empower clinicians to better understand their capabilities and adapt their approaches when integrating new technologies into their practices.

Understanding the Importance of AI in Healthcare

As AI technologies are rapidly evolving and becoming commonplace in clinical workflows, it is imperative for healthcare teams to stay ahead of the curve. The demand for specialized knowledge and training in AI applications is more pressing than ever, especially in environments dealing with limited resources. By collaborating with RCC, LiminalX aims to democratize AI knowledge, ensuring that all radiation oncology professionals, regardless of their geographic location, have access to essential educational resources.

Dr. Benjamin Li, MD, MBA, the Founder and Executive Director of Rayos Contra Cancer, expressed enthusiasm about the partnership: "RCC's mission is to empower clinicians in limited-resource settings with the knowledge and tools to deliver equitable, high-quality care for their patients... It's crucial that we have a unified framework to understand our experiences with AI in clinical practice."

Paul Naine, Founder of LiminalX, echoed this sentiment by stating, "We are thrilled to support RCC in their work empowering underserved communities where the safe use of AI has the potential to transform access and quality of care."

THRIVE's Impact on Participants

With THRIVE embedded into RCC's curriculum, the platform serves multiple purposes:

• - Building a Common Language: It enhances the dialogue around AI in medical contexts, providing a shared vocabulary that facilitates better communication among clinicians regarding the incorporation of AI tools.
• - Identifying Strengths and Gaps: Participants will engage in self-assessments that illuminate both their strengths and areas needing improvement in relation to AI readiness.
• - Informed Decision-Making: Clinicians are encouraged to approach AI tools with critical judgment, ensuring that their integration into practice is thoughtful and aligned with patient care quality.

This partnership is a testament to the importance of accessible, high-quality education in an era of rapid technological advancement. By providing a structured approach to AI readiness, LiminalX and RCC are laying the groundwork for a future where healthcare teams can confidently adopt and utilize AI technologies to enhance their practices.

Looking Ahead

As the healthcare landscape continues to evolve, the need for comprehensive training in the use of AI tools becomes paramount. The collaboration between LiminalX and Rayos Contra Cancer not only addresses immediate educational needs but also promotes a proactive approach to emerging technologies in healthcare. As AI becomes increasingly integrated into clinical workflows, this partnership positions both organizations as leaders in creating a more informed and prepared healthcare workforce worldwide.

For more information on Rayos Contra Cancer's courses, visit rayoscontracancer.org. To learn more about the THRIVE platform, check out liminal-x.ai.